[1]
|
王宁, 郑浩, 朱泽斌, 等. 腹型侵袭性纤维瘤病7例临床分析[J]. 安徽医药, 2021, 25(5): 920-922.
|
[2]
|
Sbaraglia, M., Bellan, E. and Dei, T.A. (2021) The 2020 WHO Classification of Soft Tissue Tumours: News and Perspectives. Pathologica, 113, 70-84. https://doi.org/10.32074/1591-951X-213
|
[3]
|
Penel, N., Coindre, J.M., Bonvalot, S., et al. (2016) Management of Desmoid Tumours: A Nationwide Survey of Labelled Reference Centre Networks in France. European Journal of Cancer, 58, 90-96.
https://doi.org/10.1016/j.ejca.2016.02.008
|
[4]
|
van Broekhoven, D.L., Grunhagen, D.J., den Bakker, M.A., et al. (2015) Time Trends in the Incidence and Treatment of Extra-Abdominal and Abdominal Aggressive Fibromatosis: A Population-Based Study. Annals of Surgical Oncology, 22, 2817-2823. https://doi.org/10.1245/s10434-015-4632-y
|
[5]
|
Kasper, B., Strobel, P. and Hohenberger, P. (2011) Desmoid Tu-mors: Clinical Features and Treatment Options for Advanced Disease. Oncologist, 16, 682-693. https://doi.org/10.1634/theoncologist.2010-0281
|
[6]
|
Hamada, S., Urakawa, H., Kozawa, E., et al. (2016) Charac-teristics of Cultured Desmoid Cells with Different CTNNB1 Mutation Status. Cancer Medicine, 5, 352-360. https://doi.org/10.1002/cam4.582
|
[7]
|
Nieuwenhuis, M.H., Casparie, M., Mathus-Vliegen, L.M., et al. (2011) A Nation-Wide Study Comparing Sporadic and Familial Adenomatous Polyposis-Related Desmoid-Type Fibromatoses. International Journal of Cancer, 129, 256-261.
https://doi.org/10.1002/ijc.25664
|
[8]
|
Escobar, C., Munker, R., Thomas, J.O., et al. (2012) Update on Desmoid Tumors. Annals of Oncology, 23, 562-569.
https://doi.org/10.1093/annonc/mdr386
|
[9]
|
Siaudinyte, I., Spiliauskaite, S., Arlauskiene, A., et al. (2019) Rapid Growth of a Giant Intra-Abdominal Desmoid Tumor Diagnosed during Pregnancy. The American Surgeon, 85, e204-e207.
https://doi.org/10.1177/000313481908500407
|
[10]
|
Fiore, M., Coppola, S., Cannell, A.J., et al. (2014) Des-moid-Type Fibromatosis and Pregnancy: A Multi-Institutional Analysis of Recurrence and Obstetric Risk. The American Surgeon, 259, 973-978.
https://doi.org/10.1097/SLA.0000000000000224
|
[11]
|
Santti, K., Ihalainen, H., Ronty, M., et al. (2019) Estrogen Receptor Beta Expression Correlates with Proliferation in Desmoid Tumors. Journal of Surgical Oncology, 119, 873-879. https://doi.org/10.1002/jso.25407
|
[12]
|
Kasper, B., Baumgarten, C., Garcia, J., et al. (2017) An Update on the Management of Sporadic Desmoid-Type Fibromatosis: A European Consensus Initiative between Sarcoma Patients Eu-roNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sar-coma Group (STBSG). Annals of Oncology, 28, 2399-2408. https://doi.org/10.1093/annonc/mdx323
|
[13]
|
Otero, S., Moskovic, E.C., Strauss, D.C., et al. (2015) Desmoid-Type Fibromatosis. Clinical Radiology, 70, 1038-1045.
https://doi.org/10.1016/j.crad.2015.04.015
|
[14]
|
陈烨佳, 罗振东, 吴宏洲. 腹内型侵袭性纤维瘤病的CT表现及鉴别诊断[J]. 医学影像学杂志, 2019, 29(6): 1053-1055.
|
[15]
|
Cassidy, M.R., Lefkowitz, R.A., Long, N., et al. (2020) Association of MRI T2 Signal Intensity with Desmoid Tumor Progression during Active Observation: A Retro-spective Cohort Study. The American Surgeon, 271, 748-755.
https://doi.org/10.1097/SLA.0000000000003073
|
[16]
|
Castellazzi, G., Vanel, D., Le Cesne, A., et al. (2009) Can the MRI Signal of Aggressive Fibromatosis Be Used to Predict Its Behavior? European Journal of Radiology, 69, 222-229. https://doi.org/10.1016/j.ejrad.2008.10.012
|
[17]
|
姚蓬, 李小军, 黎学兵. MRI诊断腹部侵袭性纤维瘤病的临床特点及其影像学表现分析[J]. 影像研究与医学应用, 2021, 5(18): 136-137.
|
[18]
|
吴红学, 邹力, 柯东, 等. 腹腔内侵袭性纤维瘤病临床治疗回顾[J]. 中国医药导报, 2018, 15(35): 106-109.
|
[19]
|
陈金湖, 叶青, 黄峰. 腹内型侵袭性纤维瘤病的临床特征及诊治分析[J]. 中国癌症杂志, 2018, 28(8): 622-626.
|
[20]
|
朱斌, 谢海伟, 杨小兵. 腹壁侵袭性纤维瘤病11例的临床特征及外科诊疗[J]. 江苏医药, 2016, 42(23): 2636-2637.
|
[21]
|
Micke, O. and Seegenschmiedt, M.H. (2005) Radiation Therapy for Aggressive Fibromatosis (Desmoid Tumors): Results of a National Patterns of Care Study. International Journal of Radiation Oncology, Biology, Physics, 61, 882-891.
https://doi.org/10.1016/j.ijrobp.2004.07.705
|
[22]
|
He, X.D., Zhang, Y.B., Wang, L., et al. (2015) Prognostic Fac-tors for the Recurrence of Sporadic Desmoid-Type Fibromatosis after Macroscopically Complete Resection: Analysis of 114 Patients at a Single Institution. European Journal of Surgical Oncology, 41, 1013-1019. https://doi.org/10.1016/j.ejso.2015.04.016
|
[23]
|
李云泽, 赵文嫣, 乔雷, 等. 腹壁侵袭性纤维瘤14例诊治体会[J]. 中国医科大学学报, 2021, 50(8): 759-761.
|
[24]
|
杨明, 李仕晟, 杨新明. 手术联合放疗治疗头颈部侵袭性纤维瘤病12例报道及文献复习[J]. 中国耳鼻咽喉颅底外科杂志, 2012, 18(5): 361-363.
|
[25]
|
Janssen, M.L., van Broekhoven, D.L., Cates, J.M., et al. (2017) Meta-Analysis of the Influence of Surgical Margin and Adjuvant Radio-therapy on Local Recurrence after Resection of Sporadic Desmoid-Type Fibromatosis. British Journal of Surgery, 104, 347-357. https://doi.org/10.1002/bjs.10477
|
[26]
|
Fiore, M., Rimareix, F., Mariani, L., et al. (2009) Desmoid-Type Fibromatosis: A Front-Line Conservative Approach to Select Patients for Surgical Treatment. Annals of Surgical Oncol-ogy, 16, 2587-2593.
https://doi.org/10.1245/s10434-009-0586-2
|
[27]
|
周思成, 魏然, 裴炜, 等. 侵袭性纤维瘤病多学科综合诊疗研究进展[J]. 肿瘤防治研究, 2020, 47(11): 866-870.
|
[28]
|
von Mehren, M., Kane, J.M., Bui, M.M., et al. (2020) NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021. Journal of the National Comprehensive Cancer Network, 18, 1604-1612.
https://doi.org/10.6004/jnccn.2020.0058
|
[29]
|
袁梦婷, 韩光. 侵袭性纤维瘤的靶向治疗进展[J]. 中国肿瘤临床, 2021, 48(13): 695-699.
|
[30]
|
Szucs, Z., Messiou, C., Wong, H.H., et al. (2017) Pazopanib, a Promising Option for the Treatment of Aggressive Fibromatosis. Anticancer Drugs, 28, 421-426. https://doi.org/10.1097/CAD.0000000000000474
|
[31]
|
李炫昊, 刘庆军, 杜林栋. 盆腔侵袭性纤维瘤致输尿管狭窄1例报告并文献复习[J]. 现代泌尿外科杂志, 2010, 15(3): 210-211.
|
[32]
|
Crago, A.M., Denton, B., Salas, S., et al. (2013) A Prognostic Nomogram for Prediction of Recurrence in Desmoid Fibromatosis. The American Surgeon, 258, 347-353. https://doi.org/10.1097/SLA.0b013e31828c8a30
|